CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $587,000 | -81.6% | 20,000 | -71.4% | 0.06% | -95.1% |
| Q2 2018 | $3,183,000 | +0.5% | 70,000 | +16.7% | 1.23% | -9.0% |
| Q1 2018 | $3,168,000 | +33.1% | 60,000 | +71.4% | 1.35% | -7.9% |
| Q4 2017 | $2,380,000 | -27.8% | 35,000 | -12.5% | 1.47% | +15.5% |
| Q3 2017 | $3,296,000 | – | 40,000 | – | 1.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |